Key result
Mdivi-1 increases ischemia-reperfusion survival by ~88% and reduces infarct size in hyperglycemic rats.
Why the study?
Hyperglycemia increases cardiac sensitivity to ischemia-reperfusion, but the underlying mechanisms and whether mitochondrial dynamics contribute remain unknown.
Does DRP1 inhibition with Mdivi-1 reduce ischemia-reperfusion injury and mitochondrial dysfunction in a hyperglycemic model?
Does DRP1 inhibition with Mdivi-1 reduce ischemia-reperfusion injury and mitochondrial dysfunction in a hyperglycemic model?
p-value: p=<0.05
Hyperglycemia-induced DRP1 activation alters mitochondrial calcium homeostasis and increases heart vulnerability to ischemia-reperfusion, which can be mitigated by pharmacological DRP1 inhibition.
May attenuate hyperglycemia-exacerbated IR injury in rats; hypothesis-generating for DRP1-targeted cardioprotection.
Hyperglycemia increases the heart sensitivity to ischemia-reperfusion (IR), but the underlying cellular mechanisms remain unclear. Mitochondrial dynamics (the processes that govern mitochondrial morphology and their interactions with other organelles, such as the reticulum), has emerged as a key factor in the heart vulnerability to IR. However, it is unknown whether mitochondrial dynamics contributes to hyperglycemia deleterious effect during IR. We hypothesized that (i) the higher heart vulnerability to IR in hyperglycemic conditions could be explained by hyperglycemia effect on the complex interplay between mitochondrial dynamics, Ca2+ homeostasis, and reactive oxygen species (ROS) production; and (ii) the activation of DRP1, a key regulator of mitochondrial dynamics, could play a central role. Using transmission electron microscopy and proteomic analysis, we showed that the interactions between sarcoplasmic reticulum and mitochondria and mitochondrial fission were increased during IR in isolated rat hearts perfused with a hyperglycemic buffer compared with hearts perfused with a normoglycemic buffer. In isolated mitochondria and cardiomyocytes, hyperglycemia increased mitochondrial ROS production and Ca2+ uptake. This was associated with higher RyR2 instability. These results could contribute to explain the early mPTP activation in mitochondria from isolated hearts perfused with a hyperglycemic buffer and in hearts from streptozotocin-treated rats (to increase the blood glucose). DRP1 inhibition by Mdivi-1 during the hyperglycemic phase and before IR induction, normalized Ca2+ homeostasis, ROS production, mPTP activation, and reduced the heart sensitivity to IR in streptozotocin-treated rats. In conclusion, hyperglycemia-dependent DRP1 activation results in higher reticulum-mitochondria calcium exchange that contribute to the higher heart vulnerability to IR.
No takes yet. Share an insight, caveat, or question.
Dubois et al. (2024) studied Hyperglycemia-induced cardiac vulnerability to ischemia-reperfusion injury. DRP1 inhibition (Mdivi-1) vs. Vehicle / Normoglycemic buffer was evaluated on Heart sensitivity to ischemia-reperfusion (infarct size, functional recovery, and survival) (p=<0.05). DRP1 inhibition with Mdivi-1 increased survival during ischemia-reperfusion by 88% and significantly reduced infarct size and QTc prolongation in hyperglycemic rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: